Trials that use: Covariate adjustment
5,848 results
- Pilot Testing of a Behavioral Intervention for Chronic Pain in Individuals With HIV: Complete Statistical AnalysisIndependent statistical analysis of Pilot Testing of a Behavioral Intervention for Chronic Pain in Individuals With HIV: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Piloting ‘mPal,’ a Multilevel Strategy for Palliative Care Implementation: Complete Statistical AnalysisIndependent statistical analysis of Piloting 'mPal,' a Multilevel Strategy for Palliative Care Implementation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05270395).
- PilotNR-LVADIndependent statistical analysis of Nicotinamide Riboside in LVAD Recipients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03727646).
- Pinnacle RSA Study: Complete Statistical AnalysisIndependent statistical analysis of Pinnacle RSA Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04070989).
- PINPOINTIndependent statistical analysis of Mechanisms of Active Music Engagement to Improve Health Outcomes of Children With Cancer and Parents: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- PINTIndependent statistical analysis of The Effect of Raltegravir on HIV Decay During Primary and Chronic Infection: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- PIOGASIndependent statistical analysis of Pioglitazone for Idiopathic Gastroparesis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04300127).
- Pioglitazone for the Treatment of Bipolar Depression: Complete Statistical AnalysisIndependent statistical analysis of Pioglitazone for the Treatment of Bipolar Depression: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01717040).
- Pioglitazone to Treat Fatty Liver in People With HIV Infection: Complete Statistical AnalysisIndependent statistical analysis of Pioglitazone to Treat Fatty Liver in People With HIV Infection: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00441272).
- Pioglitazone vs Placebo in Combination With Niacin Extended Release on Low HDL: Complete Statistical AnalysisIndependent statistical analysis of Pioglitazone vs Placebo in Combination With Niacin Extended Release on Low HDL: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- PIONEERIndependent statistical analysis of The Effect of Atorvastatin and Pioglitazone on Carotid Atherosclerosis With the Use of Positron Emission Tomography-computed Tomography (PET-CT): primary endpoint results, effect estimate with confidence interval, sample-size planning…
- PIONEER 4Independent statistical analysis of Efficacy and Safety of Oral Semaglutide Versus Liraglutide and Versus Placebo in Subjects With Type 2 Diabetes Mellitus: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- PIONEER AF-PCIIndependent statistical analysis of A Study Exploring Two Strategies of Rivaroxaban (JNJ39039039; BAY-59-7939) and One of Oral Vitamin K Antagonist in Patients With Atrial Fibrillation Who Undergo Percutaneous Coronary Intervention: primary endpoint…
- PITCH-EIndependent statistical analysis of Pain Inflammation and Cannabis in HIV: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05554146).
- Pivotal Study (Pharmacokinetics, Efficacy, Safety) of BAX 326 (rFIX) in Hemophilia B Patients: Complete Statistical AnalysisIndependent statistical analysis of Pivotal Study (Pharmacokinetics, Efficacy, Safety) of BAX 326 (rFIX) in Hemophilia B Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Pivotal Study in Advanced Parkinsons Disease Patients: Complete Statistical AnalysisIndependent statistical analysis of Pivotal Study in Advanced Parkinsons Disease Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00466167).
- Pivotal Study of Iodine I 131 Tositumomab for Chemotherapy-refractory Low-grade or Transformed Low-grade B-cell Non-Hodgkin’s Lymphoma: Complete Statistical AnalysisIndependent statistical analysis of Pivotal Study of Iodine I 131 Tositumomab for Chemotherapy-refractory Low-grade or Transformed Low-grade B-cell Non-Hodgkin's Lymphoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Pivotal, Multicenter, Observer-Blind, Randomized Study of Influenza A (H1N1)2009 Monovalent Subunit Vaccine With and Without Adjuvant in Children Ages 6 to <36 Months: Complete Statistical AnalysisIndependent statistical analysis of Pivotal, Multicenter, Observer-Blind, Randomized Study of Influenza A (H1N1)2009 Monovalent Subunit Vaccine With and Without Adjuvant in Children Ages 6 to
- PK Profile and Preliminary Efficacy of TNP-2092 Capsules in Liver Cirrhosis Patients With Hyperammonemia: Complete Statistical AnalysisIndependent statistical analysis of PK Profile and Preliminary Efficacy of TNP-2092 Capsules in Liver Cirrhosis Patients With Hyperammonemia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- PKUIndependent statistical analysis of Fluorodeoxyglucose Positron Emission Tomography (FDG PET) Findings in Patients With Phenylketonuria Before and After KUVAN Therapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- PlaceboIndependent statistical analysis of Efficacy of Open Label Placebo in Children With FGIDs: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02389998).
- Placebo Controled Clinical Trial Using Topiramate To Treat Posttraumatic Stress Disorder (PTSD) Patients.: Complete Statistical AnalysisIndependent statistical analysis of Placebo Controled Clinical Trial Using Topiramate To Treat Posttraumatic Stress Disorder (PTSD) Patients.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Placebo In Chronic Back Pain – Double-Blind Randomized Control Trial: Complete Statistical AnalysisIndependent statistical analysis of Placebo In Chronic Back Pain - Double-Blind Randomized Control Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02013427).
- Placebo-Controlled Trial of Antibiotic Therapy in Adults With Suspect Lower Respiratory Tract Infection (LRTI) and a Procalcitonin Level: Complete Statistical AnalysisIndependent statistical analysis of Placebo-Controlled Trial of Antibiotic Therapy in Adults With Suspect Lower Respiratory Tract Infection (LRTI) and a Procalcitonin Level: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Placebo-Corrected Effects of Therapeutic Dose (100 mg) and Supratherapeutic Dose (300 mg) of ITF2357 (Givinostat) and Moxifloxacin on QT/QTC Interval: Complete Statistical AnalysisIndependent statistical analysis of Placebo-Corrected Effects of Therapeutic Dose (100 mg) and Supratherapeutic Dose (300 mg) of ITF2357 (Givinostat) and Moxifloxacin on QT/QTC Interval: primary endpoint results, effect estimate with confidence interval,…
- Plan and Pledge, HIV Self-testing in South Africa: Complete Statistical AnalysisIndependent statistical analysis of Plan and Pledge, HIV Self-testing in South Africa: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03898557).
- PLANETIndependent statistical analysis of Aflibercept in Polypoidal Choroidal Vasculopathy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02120950).
- PLANET 1Independent statistical analysis of Prospective Evaluation of Proteinuria and Renal Function in Diabetic Patients With Progressive Renal Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Planned Donor Lymphocyte Infusion (DLI) After Allogeneic Stem Cell Transplantation (SCT): Complete Statistical AnalysisIndependent statistical analysis of Planned Donor Lymphocyte Infusion (DLI) After Allogeneic Stem Cell Transplantation (SCT): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Plasma Therapy of COVID-19 in Severely Ill Patients: Complete Statistical AnalysisIndependent statistical analysis of Plasma Therapy of COVID-19 in Severely Ill Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04359810).
- Platelet -Rich Plasma (PRP) Injection for the Treatment of Severe Dry Eye: Complete Statistical AnalysisIndependent statistical analysis of Platelet -Rich Plasma (PRP) Injection for the Treatment of Severe Dry Eye: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Play Intervention for Dementia for Promoting Cognitive Function: A Feasibility Study: Complete Statistical AnalysisIndependent statistical analysis of Play Intervention for Dementia for Promoting Cognitive Function: A Feasibility Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- PleuraSeal Post Market Study (Europe): Complete Statistical AnalysisIndependent statistical analysis of PleuraSeal Post Market Study (Europe): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00704171).
- PLHIVIndependent statistical analysis of Traditional Healers as Adherence Partners for Persons Living With HIV in Rural Mozambique: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Plinabulin vs. Pegfilgrastim in Patients With Solid Tumors Receiving Docetaxel Myelosuppressive Chemotherapy Phase 2: Complete Statistical AnalysisIndependent statistical analysis of Plinabulin vs. Pegfilgrastim in Patients With Solid Tumors Receiving Docetaxel Myelosuppressive Chemotherapy Phase 2: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Ploidy and Stroma in Early Rectal Cancer: Complete Statistical AnalysisIndependent statistical analysis of Ploidy and Stroma in Early Rectal Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03039595).
- PLUMIndependent statistical analysis of Post-Prandial Liver Glucose Metabolism in PCOS: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03041129).
- PLUSIndependent statistical analysis of Improving HIV and Alcohol-Related Outcomes Among HIV+ Persons in Clinic Settings: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- PLX038 (PEGylated SN38) and Rucaparib in Solid Tumors and Small Cell Cancers: Complete Statistical AnalysisIndependent statistical analysis of PLX038 (PEGylated SN38) and Rucaparib in Solid Tumors and Small Cell Cancers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- PMS-001Independent statistical analysis of An Open-Label Study of Oral NNZ-2591 in Phelan-McDermid Syndrome (PMS-001): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05025241).
- pNAATIndependent statistical analysis of Performance of Nucleic Acid Amplification Tests for the Detection of NG and CT: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- PNPIndependent statistical analysis of BlueWind Medical Reprieve System for the Treatment of PNP: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02062398).
- POC1Independent statistical analysis of Evaluation of Doxycycline Verses Placebo for the Treatment of Severe Nonproliferative or Mild or Moderate Proliferative Diabetic Retinopathy: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- POCHARBIIndependent statistical analysis of Impact of Chemotherapy Followed by Aromatase Inhibitors on Bone Health of Women With ER-positive Early Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- PODOIndependent statistical analysis of A Study to Evaluate PF-06730512 in Adults With Focal Segmental Glomerulosclerosis (FSGS): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- POEMIndependent statistical analysis of POEM (Practice Of Embracing Each Moment) STUDY: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03078608).
- POGOIndependent statistical analysis of Pediatric Cardiac Output Monitoring Observational Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04465370).
- POINTIndependent statistical analysis of Pediatric Oncology Nutrition Intervention Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT06175273).
- POINTIndependent statistical analysis of Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- POINTSIndependent statistical analysis of The Personalized Nutrition Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04145466).